Adagio Medical Holdings, Inc. (ADGM)
NASDAQ: ADGM · Real-Time Price · USD
0.6835
-0.0485 (-6.63%)
At close: Aug 7, 2026, 4:00 PM EDT
0.6701
-0.0134 (-1.96%)
After-hours: Aug 7, 2026, 7:56 PM EDT
Adagio Medical Holdings Employees
Adagio Medical Holdings had 41 employees as of December 31, 2025. The number of employees decreased by 39 or -48.75% compared to the previous year.
Employees
41
Change (1Y)
-39
Growth (1Y)
-48.75%
Revenue / Employee
n/a
Profits / Employee
-$594,293
Market Cap
15.18M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 41 | -39 | -48.75% |
| Dec 31, 2024 | 80 | -5 | -5.88% |
| Jun 30, 2024 | 87 | - | - |
| Dec 31, 2023 | 85 | -12 | -12.37% |
| Dec 31, 2022 | 97 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Trinity Biotech | 287 |
| Cytosorbents | 129 |
| Co-Diagnostics | 115 |
| IRIDEX | 93 |
| Lifeward | 81 |
| Pulsenmore | 71 |
| IceCure Medical | 69 |
| Modular Medical | 51 |
ADGM News
- 6 days ago - Adagio Medical treats first patient with vCLAS Ultra ULTA system - TheFly
- 6 days ago - Adagio Medical Treats First Patient with Faster, Single-Freeze Next-Generation ULTA System - Business Wire
- 7 weeks ago - Adagio Medical Holdings Transcript: AGM 2026 - Transcripts
- 2 months ago - Adagio Medical initiated with a Buy at Lucid Capital - TheFly
- 2 months ago - Adagio Medical submits PMA application to FDA for vCLAS Ventricular Ablation - TheFly
- 2 months ago - Adagio Medical Submits Premarket Approval Application to FDA for vCLAS® Ventricular Ablation System for the Treatment of Ventricular Tachycardia - Business Wire
- 3 months ago - Adagio Medical Holdings Transcript: BofA Securities 2026 Health Care Conference - Transcripts
- 3 months ago - Adagio Medical Holdings Slides: FY 2026 - Filings